Screening and surveillance of Barrett's esophagus

Current Gastroenterology Reports

Volumn 11, Issue 3, 2009, Pages 195-201

  Michalak, Jeff ^a   Bansal, Ajay ^a   Sharma, Prateek ^a  

^a UNIVERSITY OF KANSAS SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOFLUORESCENCE IMAGING; BARRETT ESOPHAGUS; CANCER SURVIVAL; CAPSULE ENDOSCOPY; CAUCASIAN; CHROMOENDOSCOPY; COLUMNAR EPITHELIUM; CONFOCAL MICROSCOPY; DISEASE COURSE; DISEASE DURATION; DISEASE SURVEILLANCE; DYSPLASIA; ENDOSCOPY; ESOPHAGEAL ADENOCARCINOMA; ESOPHAGOGASTRODUODENOSCOPY; GASTROESOPHAGEAL REFLUX; HEARTBURN; HIGH RESOLUTION ENDOSCOPY; HISTOPATHOLOGY; HUMAN; INTESTINE METAPLASIA; NARROW BAND IMAGING; OBESITY; PREDICTION; PREVALENCE; RACE DIFFERENCE; REVIEW; RISK FACTOR; SCREENING TEST; SEX DIFFERENCE; SPECTROSCOPY;

BARRETT ESOPHAGUS; DISEASE PROGRESSION; ENDOSCOPY, GASTROINTESTINAL; ESOPHAGEAL NEOPLASMS; HUMANS; INCIDENCE; MASS SCREENING; POPULATION SURVEILLANCE; PRECANCEROUS CONDITIONS; PREVALENCE; UNITED STATES;

EID: 66149101367     PISSN: 15228037     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11894-009-0031-5     Document Type: Review

References (54)

1. Holmes RS, Vaughan TL: Epidemiology and pathogenesis of esophageal cancer. Semin Radiat Oncol 2007, 17:2-9.
2. Eloubeidi MA, Mason AC, Desmond RA, El-Serag HB: Temporal trends (1973-1997) in survival of patients with esophageal adenocarcinoma in the United States: A glimmer of hope? Am J Gastroenterol 2003, 98:1627-1633.
3. Sharma P, McQuaid K, Dent J, et al.: A critical review of the diagnosis and management of Barrett's esophagus: The AGA Chicago workshop. Gastroenterology 2004, 127:310-330.
4. Haggitt RC: Barrett's esophagus, dysplasia, and adenocarcinoma. Hum Pathol 1994, 25:982-993.
5. Sampliner RE: A population prevalence of Barrett's esophagus - finally. Gastroenterology 2005, 129:2101-2103.
6. Ronkainen J, Aro P, Storskrubb T, et al.: Prevalence of Barrett's esophagus in the general population: An endoscopic study. Gastroenterology 2005, 129:1825-1831.
7. Veldhuyzen van Zanten SJ, Thomson AB, Barkun AN, et al.: The prevalence of Barrett's oesophagus in a cohort of 1040 Canadian primary care patients with uninvestigated dyspepsia undergoing prompt endoscopy. Aliment Pharmacol Ther 2006, 23:595-599.
8. Kulig M, Nocon M, Vieth M, et al.: Risk factors of gastroesophageal reflux disease: Methodology and first epidemiological results of the ProGERD study. J Clin Epidemiol 2004, 57:580-589.
9. Locke GR, Zinsmeister AR, Talley NJ: Can symptoms predict endoscopic findings in GERD? Gastrointest Endosc 2003, 58:661-670.
10. Wani S, Rastogi A, Bansal A, et al.: Symptom profiles and endoscopic findings in African-American patients with gastroesophageal reflux disease (GERD). Gastroenterology 2007, 132(Suppl):A-161.
11. Spechler SJ, Jain SK, Tendler DA, Parker RA: Racial differences in the frequency of symptoms and complications of gastro-oesophageal reflux disease. Aliment Pharmacol Ther 2002, 16:1795-1800.
12. Eloubeidi MA, Provenzale D: Clinical and demographic predictors of Barrett's esophagus among patients with gastroesophageal reflux disease: a multivariable analysis in veterans. J Clin Gastroenterol 2001, 33:306-309.
13. El-Serag HB, Gilger MA, Shub MD, et al.: The prevalence of suspected Barrett's esophagus in children and adolescents: A multicenter endoscopic study. Gastrointest Endosc 2006, 64:671-675.
14. Ochs-Balcom HM, Falk G, Grady WM, et al.: Consortium approach to identifying genes for Barrett's esophagus and esophageal adenocarcinoma. Transl Res 2007, 150:3-17.
15. Rubenstein JH, Sonnenberg A, Davis J, et al.: Effect of a prior endoscopy on outcomes of esophageal adenocarcinoma among United States veterans. Gastrointest Endosc 2008, 68:849-855.
16. Wang KK, Sampliner RE: Updated guidelines 2008 for the diagnosis, surveillance, and therapy of Barrett's esophagus. Am J Gastroenterol 2008, 103:788-797.
17. Kahrilas PJ, Shaheen NJ, Vaezi MF: American Gastroenterological Association Institute technical review on the management of gastroesophageal reflux disease. Gastroenterology 2008, 135:1392-1413.
18. Murray L, Watson P, Johnston B, et al.: Risk of adenocarcinoma in Barrett's oesophagus: Population based study. BMJ 2003, 327:534-535.
19. Oberg S, Johansson J, Wenner J, et al.: Endoscopic surveillance of columnar-lined esophagus: Frequency of intestinal metaplasia detection and impact of antireflux surgery. Ann Surg 2001, 234:619-626.
20. Kim SL, Waring JP, Spechler SJ, et al.: Diagnostic inconsistencies in Barrett's esophagus. Department of Veterans Affairs Gastroesophageal Reflux Study Group. Gastroenterology 1994, 107:945-949.
21. Jones TF, Sharma P, Daaboul B, et al.: Yield of intestinal metaplasia in patients with suspected short-segment Barrett's esophagus (SSBE) on repeat endoscopy. Dig Dis Sci 2002, 47:2108-2111.
22. Schnell TG, Sontag SJ, Chejfec G: Adenocarcinomas arising in tongues or short segments of Barrett's esophagus. Dig Dis Sci 1992, 37: 137-143.
23. Gerson LB, Shetler K, Triadafilopoulos G: Prevalence of Barrett's esophagus in asymptomatic individuals. Gastroenterology 2002, 123:461-467.
24. Ward EM, Wolfsen HC, Achem SR, et al.: Barrett's esophagus is common in older men and women undergoing screening colonoscopy regardless of reflux symptoms. Am J Gastroenterol 2006, 101: 12-17.
25. Eliakim R, Sharma VK, Yassin K, et al.: A prospective study of the diagnostic accuracy of PillCam ESO esophageal capsule endoscopy versus conventional upper endoscopy in patients with chronic gastroesophageal reflux diseases. J Clin Gastroenterol 2005, 39:572-578.
26. Sharma P, Wani S, Rastogi A, et al.: The diagnostic accuracy of esophageal capsule endoscopy in patients with gastroesophageal reflux disease and Barrett's esophagus: A blinded, prospective study. Am J Gastroenterol 2008, 103:525-532.
27. Ramirez FC, Shaukat MS, Young MA, et al.: Feasibility and safety of string, wireless capsule endoscopy in the diagnosis of Barrett's esophagus. Gastrointest Endosc 2005, 61:741-746.
28. Jobe BA, Hunter JG, Chang EY, et al.: Office-based unsedated small-caliber endoscopy is equivalent to conventional sedated endoscopy in screening and surveillance for Barrett's esophagus: A randomized and blinded comparison. Am J Gastroenterol 2006, 101:2693-2703.
29. Sharma P, Bansal A: Toward better imaging of Barrett's esophagus - see more, biopsy less! Gastrointest Endosc 2006, 64:188-192.
30. Kiesslich R, Gossner L, Goetz M, et al.: In vivo histology of Barrett's esophagus and associated neoplasia by confocal laser endomicroscopy. Clin Gastroenterol Hepatol 2006, 4:979-987.
31. Groisman GM, Amar M, Meir A: Expression of the intestinal marker Cdx2 in the columnar-lined esophagus with and without intestinal (Barrett's) metaplasia. Mod Pathol 2004, 17:1282-1288.
32. Wong A, Fitzgerald RC: Epidemiologic risk factors for Barrett's esophagus and associated adenocarcinoma. Clin Gastroenterol Hepatol 2005, 3:1-10.
33. Rogers EL, Goldkind SF, Iseri OA, et al.: Adenocarcinoma of the lower esophagus. A disease primarily of white men with Barrett's esophagus. J Clin Gastroenterol 1986, 8: 613-618.
34. El-Serag HB, Petersen NJ, Carter J, et al.: Gastroesophageal reflux among different racial groups in the United States. Gastroenterology 2004, 126:1692-1699.
35. Lagergren J, Bergstrom R, Lindgren A, Nyren O: Symptomatic gastroesophageal reflux as a risk factor for esophageal adenocarcinoma. N Engl J Med 1999, 340:825-831.
36. Hampel H,OAbraham NS, El-Serag HB: Meta-analysis: obesity and the risk for gastroesophageal reflux disease and its complications. Ann Intern Med 2005, 143:199-211.
37. Odze RD: Diagnosis and grading of dysplasia in Barrett's oesophagus. J Clin Pathol 2006, 59:1029-1038.
38. Rastogi A, Sharma P, El-Serag HB, et al.: Incidence of esophageal adenocarcinoma in patients with Barrett's esophagus and high grade dysplasia: A meta analysis. Gastrointest Endosc 2008, 67:394-398.
39. Montgomery E, Bronner MP, Goldblum JR, et al.: Reproducibility of the diagnosis of dysplasia in Barrett esophagus: A reaffirmation. Hum Pathol 2001, 32:368-378.
40. Kerkhof M, van Dekken H, Steyerberg EW, et al.: Grading of dysplasia in Barrett's oesophagus: Substantial interobserver variation between general and gastrointestinal pathologists. Histopathology 2007, 50:920-927.
41. Chatelain D, Flejou JF: High-grade dysplasia and superficial adenocarcinoma in Barrett's esophagus: Histological mapping and expression of p53, p21 and Bcl-2 oncoproteins. Virchows Arch 2003, 442:18-24.
42. Puli S, Mathur S, Bansal A, Sharma P: Development of esophageal adenocarcinoma in patients with Barrett's esophagus and high grade dysplasia undergoing surveillance: A meta-analysis and systematic review. Gastrointest Endosc 2006, 63:AB82.
43. Sharma P: Low-grade dysplasia in Barrett's esophagus. Gastroenterology 2004, 127:1233-1238.
44. Srivastava A, Hornick JL, Li X, et al.: Extent of low-grade dysplasia is a risk factor for the development of esophageal adenocarcinoma in Barrett's esophagus. Am J Gastroenterol 2007, 102:483-493; quiz 694.
45. Lim CH, Treanor D, Dixon MF, Axon AT: Low-grade dysplasia in Barrett's esophagus has a high risk of progression. Endoscopy 2007, 39:581-587.
46. Weston AP, Banerjee SK, Sharma P, et al.: P53 protein overexpression in low grade dysplasia (LGD) in Barrett's esophagus: Immunohistochemical marker predictive of progression. Am J Gastroenterol 2001, 96:1355-1362.
47. Horwhat JD, Maydonovitch CL, Ramos F, et al.: A randomized comparison of methylene blue-directed biopsy versus conventional four-quadrant biopsy for the detection of intestinal metaplasia and dysplasia in patients with long-segment Barrett's esophagus. Am J Gastroenterol 2008, 103:546-554.
48. Sharma P, Bansal A, Mathur S, et al.: The utility of a novel narrow band imaging endoscopy system in patients with Barrett's esophagus. Gastrointest Endosc 2006, 64:167-175.
49. Kara MA, Peters FP, Rosmolen WD, et al.: High-resolution endoscopy plus chromoendoscopy or narrow-band imaging in Barrett's esophagus: A prospective randomized crossover study. Endoscopy 2005, 37:929-936.
50. Wolfsen HC, Crook JE, Krishna M, et al.: Prospective, controlled tandem endoscopy study of narrow band imaging for dysplasia detection in Barrett's esophagus. Gastroenterology 2008, 135:24-31.
51. Curvers WL, Singh R, Wong Kee Song LM, et al.: Endoscopic tri-modal imaging for detection of early neoplasia in Barrett's oesophagus; a multi-centre feasibility study using high-resolution endoscopy, autofluorescence imaging and narrow band imaging incorporated in one endoscopy system. Gut 2008, 57:167-172.
52. Pohl H, Koch M, Khalifa A, et al.: Evaluation of endocytoscopy in the surveillance of patients with Barrett's esophagus. Endoscopy 2007, 39:492-496.
53. Rabinovitch PS, Longton G, Blount PL, et al.: Predictors of progression in Barrett's esophagus III: Baseline flow cytometric variables. Am J Gastroenterol 2001, 96:3071-3083.
54. van Sandick JW, Baak JP, van Lanschot JJ, et al.: Computerized quantitative pathology for the grading of dysplasia in surveillance biopsies of Barrett's oesophagus. J Pathol 2000, 190:177-183.